Efficacy and Tolerability of Zolmitriptan Nasal Spray
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and tolerability (the ability not
to experience ill effects from the study drug) of a zolmitriptan nasal spray, 5.0 mg,
compared with placebo (inactive drug) for 2 migraine headaches for up to 12 weeks in adult
subjects with migraine headaches